pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 425 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
(nebivolol hydrochloride + valsartan)
Vyduo ((nebivolol hydrochloride + valsartan))
Hypertension
Prinston Pharmaceutical Inc
0 catalysts
Marketed
(sacubitril + valsartan)
Sacubitril + Valsartan ((sacubitril + valsartan))
Cardiovascular Risk Factors
Novugen Pharma (Malaysia) Sdn Bhd
0 catalysts
Marketed
(trandolapril + verapamil hydrochloride) ER
Trandolapril + Verapamil Hydrochloride ((trandolapril [INN] + verapamil hydrochloride))
Hypertension
Glenmark Pharmaceuticals Ltd
0 catalysts
← prev
page 5 of 15
next →
131
Pain89
Neurology1
Phase 2
AB-002
Thrombosis
Lysyl oxidase homolog 2
Aronora Inc
0 catalysts
Phase 2
ACP-01
Vescell
Chronic Stable Angina
Hemostemix Inc
0 catalysts
Phase 2
AFTX-201
Dilated Cardiomyopathy
Affinia Therapeutics Inc
0 catalysts
Phase 1
AH-101
Congestive Heart Failure (Heart Failure)
Acahealth Pharma and Biotech Co Ltd
0 catalysts
Preclinical
AMB-101
Critical Limb Ischemia
Ambulero Inc
0 catalysts
Preclinical
AMB-301
Thromboangiitis obliterans (Buerger disease)
Ambulero Inc
0 catalysts
Preclinical
ASD-006
Atherosclerosis
Asdera LLC
0 catalysts
pre_registration
ASN-006
Venous Thromboembolism
Auson Pharmaceuticals Inc
0 catalysts
Phase 1
ATI-1013
Thromboangiitis obliterans (Buerger disease)
Antidote Therapeutics Inc
0 catalysts
Preclinical
ATLX–0199
Unspecified Cardiovascular Disorders
Atelerix Life Sciences Inc
0 catalysts
Preclinical
Atrial Fibrillation
Atrial Fibrillation
Inomagen Therapeutics Inc
0 catalysts
Phase 2
BGC-101
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD)
BiogenCell Ltd
0 catalysts
Marketed
Bicillin L A
Bicillin L A (penicillin G benzathine)
Upper Respiratory Tract Infections by Streptococcus pyogenes
$PFEPFIZER INC
0 catalysts
Phase 1
CBP-4888
Pre-Eclampsia
Comanche Biopharma Corp
0 catalysts
Phase 2
CST-3056
Neurogenic Orthostatic Hypotension (nOH)
CuraSen Therapeutics Inc
0 catalysts
Phase 2
CardiALLO
Systolic Heart Failure (HFrEF)
$BCDABioCardia, Inc.
0 catalysts
Phase 3
CardiAMP
Myocardial Ischemia
$BCDABioCardia, Inc.
0 catalysts
Phase 2
Carfostin
Non-ischemic Cardiomyopathy
Asklepios BioPharmaceutical Inc
0 catalysts
Phase 2
DF-003
Chronic Kidney Disease (Chronic Renal Failure)
Drug Farm Inc
0 catalysts
Preclinical
Dekaparin
Deep Vein Thrombosis (DVT)
Glycan Therapeutics Inc
0 catalysts
Preclinical
EL-100
Critical Limb Ischemia
Elphis Cell Therapeutics Co Ltd
0 catalysts
Preclinical
Elsartan
Hypertension
Eldrug SA
0 catalysts
Phase 1
FBHRS-001
Atrial Fibrillation
FB HRS LLC
0 catalysts
Phase 2
FGF-1
Coronary Artery Disease (CAD) (Ischemic Heart Disease)
Zhittya Genesis Medicine Inc
0 catalysts
Phase 1
GMA-301
Pulmonary Arterial Hypertension
Gmax Biopharm LLC
0 catalysts
Phase 2
GP-531
Congestive Heart Failure (Heart Failure)
ViCardia Therapeutics Inc
0 catalysts
Preclinical
GXV-002
Pulmonary Arterial Hypertension
GEXVal Inc
0 catalysts